Y-site Compatibility of Intravenous Nefopam with Medications Commonly Used in Intensive Care Units
3PC-032
Optimising Analgosedation in the Intensive Care Unit during the SARS-COV-2 Pandemic
3PC-030
Different substrates for orodispersible films: You have the choice!
3PC-023
Investigation of Leachable Compounds In water for injection used in hospital pharmacy
3PC-021
DESIGN AND ELABORATION OF METRONIDAZOLE 1% TOPICAL SOLUTION FOR TREATMENT OF ULCERS INFECTED BY ANAEROBIC BACTERIA
3PC-019
EVALUATION OF THE IMPACT OF MACHINE-AIDED DEBLISTERING IN UNIT DOSE BLISTER PRODUCTION ON THE FUNCTIONALITY OF TABLET COATING
3PC-018
COMPATIBILITY AND 30-DAY STABILITY OF FOUR INTRAVENOUS MIXTURES FOR MULTIMODAL ANALGESIA
3PC-010
Assessment of Chemfort (OnGuard, US) Syringe Adaptor Lock Fitted With Luer Lock Syringes to Container Integrity Standards (NHS, UK) Supporting Dose Banding of Cytotoxic Drugs
3PC-008
TIMES AND ERRORS FOR DISPENSING NARCOTICS DRUGS IN AUTOMATED SYSTEM VERSUS MANUAL SYSTEM
3PC-001
CHOLESTEROL 2%/SIMVASTATIN 1% OINTMENT FOR THE TREATMENT OF POROKERATOSIS PTYCHOTROPICA: A CASE REPORT
3PC-073
EVALUATION OF ANTIOBIOTICS' PHYSICOCHEMICAL INCOMPATIBILITY WITH THE PRESENCE OF DIVALENT CATIONS
3PC-072
WHICH MODEL TO ESTIMATE AT BEST THE THEORETICAL OSMOLARITY OF NOMINATIVE PARENTERAL NUTRITION?
3PC-071
FULLY AUTOMATED CENTRAL INTRAVENOUS ADDITIVE SERVICE (CIVAS): A 12 MONTH ANALYSIS OF PERFORMANCES AND IMPACT OF COVID-19 ON STERILE ANTIBIOTICS PRODUCTION
3PC-070
EVALUATION OF COMPATIBILITY OF ACETYLSALICYLIC ACID AND ATENOLOL WITH MEDICATIONS COMMONLY USED IN INTENSIVE CARE UNITS
